Clinical Guides
Reactive Arthritis
A clinically focused clinical guide to diagnosing reactive arthritis after gastrointestinal or genitourinary infection, excluding septic arthritis, treating active infection, and planning safe India-contextualised follow-up.
MedNext Academy | 13 min read
Reactive Arthritis
A clinically focused clinical guide to diagnosing reactive arthritis after gastrointestinal or genitourinary infection, excluding septic arthritis, treating active infection, and planning safe India-contextualised follow-up.
Summary
Reactive arthritis is a sterile inflammatory arthritis that follows an infection elsewhere, classically in the gastrointestinal or genitourinary tract. Symptoms commonly begin about one to four weeks after the triggering illness. The characteristic musculoskeletal pattern is acute asymmetric oligoarthritis of the lower limbs, often with enthesitis or dactylitis. Urethritis or cervicitis, conjunctivitis, anterior uveitis, oral lesions, keratoderma blennorrhagicum and circinate balanitis may occur, but the historical triad of arthritis, urethritis and conjunctivitis is neither required nor usually complete.
Diagnosis is clinical and exclusionary. There is no single confirmatory reactive-arthritis test, and a preceding infection may have been mild or resolved before joints become inflamed. The immediate priority in any acute hot joint is to exclude septic arthritis, including disseminated gonococcal infection where relevant. Synovial-fluid analysis, microbiology and crystal examination are therefore central when a significant effusion is accessible. HLA-B27 may relate to phenotype or persistence but cannot establish or exclude the diagnosis.
Management separates two questions. Treat a current triggering infection and its transmission implications according to the applicable national or local guideline; do not assume that antibiotics eradicate established sterile arthritis. current guidelines specifically advises against antibiotics for four weeks or longer solely to manage reactive arthritis after a gastrointestinal or genitourinary infection once the initial infection has been treated. Control joint inflammation with an individualised NSAID, local or short systemic glucocorticoid when appropriate, rehabilitation and specialist escalation for persistent disease. Eye pain, photophobia, reduced vision, systemic toxicity or a septic-joint phenotype needs urgent care.
How Common Is It?
The true frequency of reactive arthritis is uncertain because triggers can be asymptomatic, stool or genital testing may be delayed, diagnostic terminology varies and mild cases resolve without specialist review. Only a minority of people with a recognised gastrointestinal or genitourinary infection develop arthritis. Reported rates differ by organism, outbreak, study design and host population. It is therefore misleading to quote a single risk after all infections or to apply a foreign clinic cohort directly to India.
Reactive arthritis occurs most often in younger adults, although it can affect people of any sex and age. Sex distributions vary with ascertainment: sexually acquired disease has historically been recognised more often in men, while post-enteric disease is not restricted in the same way. The condition often improves over weeks to months, and public health clinical information notes that many episodes resolve within six months. Some patients relapse, develop persistent arthritis, enthesitis or inflammatory back pain, or evolve into a chronic spondyloarthritis phenotype.
India-specific national incidence is not established by the cited NACO or NMC documents. NACO describes a heterogeneous STI/RTI burden and variable access to laboratory diagnosis, while gastrointestinal infections and outbreaks also differ geographically. These facts affect case finding but do not provide a denominator for reactive arthritis. Clinicians should describe the syndrome as uncommon and probably under-recognised rather than claim a precise national prevalence. For the individual patient, the timing, inflammatory pattern, microbiological context and exclusion of emergencies matter more than a population statistic.
Risk Factors
A recent infection is the defining exposure. Recognised genitourinary triggers include Chlamydia trachomatis; enteric triggers include Salmonella, Shigella, Campylobacter and Yersinia species. Infection may have caused diarrhoea, dysuria, discharge, pelvic symptoms or no recalled symptoms. Sexual history should be confidential, anatomically specific and non-judgemental, covering sites of exposure, barrier use, partners, pregnancy possibility and previous STI testing. Food, travel, water, household and outbreak exposures help interpret enteric illness.
HLA-B27 is associated with the spondyloarthritis family and may be linked to more severe, axial or persistent disease in some cohorts, but it is not a screening test for exposure and does not prove causation. Most people carrying HLA-B27 never develop reactive arthritis, and a negative result does not rule it out. Family or personal history of psoriasis, inflammatory bowel disease, uveitis or spondyloarthritis may indicate an alternative or evolving chronic diagnosis rather than a simple self-limited episode.
Risk assessment must also cover infection and treatment harms. Immunosuppression, prosthetic joint, recent surgery or injection, skin infection, diabetes, older age and bacteraemia risk increase concern for septic arthritis. Pregnancy, kidney disease, peptic ulcer, anticoagulation, cardiovascular disease, liver disease and asthma may alter NSAID or glucocorticoid choices. HIV status can change the differential and care pathway. Repeated unprotected exposure or untreated partners increases reinfection risk. None of these factors replaces aspiration of a suspicious joint or diagnostic testing for an active infection.
Diagnosis
Reactive arthritis is considered when inflammatory musculoskeletal symptoms follow a plausible infection and competing diagnoses have been addressed. Do not delay emergency septic-arthritis management while assembling a complete extra-articular pattern.
History
Document joint onset, sequence, number and distribution; morning stiffness; heel or plantar pain; sausage digits; inflammatory back or buttock pain; and functional loss. Ask about diarrhoea, abdominal cramps or fever in the preceding four weeks and about dysuria, genital discharge, pelvic pain, abnormal bleeding and sexual exposures. Enquire about eye redness, pain, photophobia or blurred vision; oral ulcers; palm, sole or genital lesions; psoriasis; inflammatory bowel symptoms; preceding medicines, travel and outbreaks. Record antibiotic exposure because it changes culture yield.
Examination
Measure vital signs and assess toxicity. Count tender and swollen joints, looking particularly at knees, ankles and feet. Examine entheses, digits, sacroiliac provocation and spine, while documenting skin warmth or erythema across skin tones. Inspect skin, nails and visible mucosa sensitively; genital examination requires consent, privacy and an appropriate chaperone. Distinguish simple conjunctivitis from possible uveitis by asking about pain, photophobia and vision. Look for psoriasis, keratoderma, balanitis, cervicitis or discharge without assuming absence excludes infection.
Investigations
A hot swollen joint usually requires aspiration for appearance, cell count and differential, Gram stain, bacterial culture and crystals; send additional tests according to exposure and laboratory advice. Obtain blood cultures if febrile or septic. CRP, ESR and full blood count describe inflammation but are nonspecific. Use nucleic-acid testing for chlamydia and gonorrhoea from exposure-appropriate sites, plus HIV and syphilis testing according to consent and national guidance. Stool culture or molecular testing is most useful during active diarrhoea or an outbreak. HLA-B27, ultrasound, radiographs or MRI answer selected prognostic or differential questions; they are not routine confirmation tests.
Differential Diagnosis
Septic arthritis is the first dangerous alternative. Fever may be absent, especially after antibiotics or in immunocompromise. A single intensely painful joint, inability to bear weight, marked movement restriction, bacteraemia risk or systemic illness should trigger aspiration and urgent treatment pathways. Disseminated gonococcal infection can produce migratory pain, tenosynovitis, dermatitis or purulent arthritis and may coexist with minimal genital symptoms. Crystal arthritis can mimic infection and crystals do not exclude simultaneous sepsis.
Other spondyloarthritis conditions overlap. Psoriatic arthritis is suggested by psoriasis, nail dystrophy, persistent dactylitis or a typical family history. Axial spondyloarthritis becomes more likely with enduring inflammatory back pain, sacroiliitis and recurrent uveitis. Enteropathic arthritis accompanies inflammatory bowel disease rather than a brief infectious gastroenteritis. Rheumatoid arthritis usually produces persistent symmetrical small-joint synovitis, while palindromic rheumatism, sarcoidosis and Behçet disease have their own patterns. Acute rheumatic fever requires evidence of preceding group A streptococcal infection and Jones-criteria manifestations.
Viral arthritis, chikungunya, dengue-related arthralgia, parvovirus, hepatitis and HIV can present with polyarthralgia or arthritis in India. Lyme disease is exposure-dependent and should not be imported into every differential. Mechanical injury, internal derangement, bursitis and cellulitis may mimic a local inflammatory joint. Drug reactions, vasculitis and inflammatory bowel infection complications also matter. The diagnosis should be revisited if onset is poorly timed to infection, the pattern is persistently symmetrical, inflammatory markers stay high without improvement, symptoms exceed the expected course, or immunosuppression is repeatedly required. A trigger detected by PCR does not automatically prove that every joint symptom is reactive arthritis.
Management
Begin by triaging sepsis, severe eye disease and ongoing infection. Aspirate a suspicious joint before antibiotics when this can be done safely without delaying treatment. If septic arthritis is clinically likely, follow the emergency antimicrobial and drainage pathway rather than treating with anti-inflammatory drugs alone. Anterior uveitis requires urgent ophthalmology. For uncomplicated reactive arthritis, explain that inflammation occurs after infection and is not the same as bacteria growing inside the joint.
Treat any active gastrointestinal or genitourinary infection according to organism, syndrome, pregnancy status, antimicrobial susceptibility and the current Indian or local guideline. For a sexually transmitted trigger, manage partners, transmission reduction and appropriate testing confidentially. Current guidelines advises that after the initial infection has been treated, antibiotics lasting four weeks or longer should not be offered solely to control reactive arthritis. Persistent urinary or genital symptoms require reassessment for reinfection, non-adherence, untreated partners or another pathogen, not an automatic prolonged course.
Use rest briefly during severe synovitis but preserve daily movement. An NSAID is typical first-line anti-inflammatory therapy when renal, gastrointestinal and cardiovascular risks permit. A single or few inflamed joints or entheses may benefit from local glucocorticoid after infection has been excluded; a short systemic course may be considered for severe multi-site disease under supervision. Physiotherapy should restore range, strength and gait without forcing an acutely inflamed joint. Persistent arthritis may require rheumatology-directed sulfasalazine, methotrexate or, rarely, biologic therapy after infection screening. Review recovery, function, eye symptoms, skin disease and evolution toward chronic spondyloarthritis.
Prescribing Information
Do not issue an anti-inflammatory prescription until septic arthritis and relevant contraindications have been considered. If an NSAID is appropriate, choose one agent at the lowest effective dose for the shortest necessary course. Record renal function, blood pressure, gastrointestinal-ulcer or bleeding history, cardiovascular disease, pregnancy, asthma reactions and concurrent anticoagulants, antiplatelets, steroids or other NSAIDs. Avoid combining NSAIDs, and add gastroprotection only according to verified risk and local policy. Give a stop-and-seek-help plan for melaena, haematemesis, dyspnoea, oedema, reduced urine or allergic symptoms.
Intra-articular glucocorticoid requires correct joint identification, aseptic technique, documented preparation and dose, and reasonable exclusion of bacterial infection. Systemic glucocorticoids can obscure fever and infection, raise glucose and cause mood, sleep and gastrointestinal effects; use a defined short plan with review rather than open-ended repeats. DMARDs and biologics require specialist diagnosis, baseline infection screening, laboratory monitoring, pregnancy counselling where relevant and vaccination planning. Persistent symptoms should not be managed by escalating steroids before reviewing the diagnosis.
Antibiotics treat the infection, not automatically the arthritis. Follow NACO's current 2024 STI/RTI tables and local antimicrobial policy for Indian care; regimen choice depends on syndrome, laboratory result, pregnancy, allergy and coinfection. CDC's doxycycline regimen is a foreign reference and must not override Indian requirements. Counsel on adherence, abstaining from sexual contact until treatment requirements are met, partner evaluation and retesting when indicated. Do not give prolonged antibiotics solely for post-enteric or post-genitourinary arthritis, and do not treat an isolated positive antibody as evidence of active infection.
When to Refer
Send a patient with a possible septic joint for same-day emergency orthopaedic or medical assessment. Referral information should include onset, joint, temperature, immunosuppression, prosthesis, recent procedure, skin or bloodstream infection, antibiotics already taken and aspiration status. Do not defer because the patient also reports diarrhoea or urethritis; infection within a joint and a reactive process are not safely separated without assessment.
Refer urgently to ophthalmology for eye pain, photophobia, reduced vision or marked unilateral redness because anterior uveitis can threaten sight. Simple conjunctivitis may be less urgent, but diagnostic uncertainty should favour examination. Sexual-health, dermatology or gynaecology referral may be needed for complicated STI, pelvic symptoms, persistent genital lesions, pregnancy, treatment failure, assault or safeguarding concerns. NACO's public pathways include designated STI/RTI services, but availability must be confirmed locally.
Rheumatology referral is appropriate for diagnostic uncertainty, marked polyarthritis, axial symptoms, recurrent uveitis, failure of an adequate NSAID strategy, contraindication to standard anti-inflammatory therapy, persistent symptoms beyond several weeks, relapse, or consideration of injection, DMARD or biologic therapy. Also refer if psoriasis, inflammatory bowel disease or another systemic diagnosis is emerging. Physiotherapy supports recovery when acute inflammation is controlled. A high-quality referral states the suspected trigger, microbiological results, synovial-fluid findings, extra-articular features, treatment and response. Provide interim eye and sepsis safety-netting rather than waiting passively for a routine appointment.
Red Flags
An acutely hot, swollen, severely painful joint with fever, rigors, hypotension or inability to bear weight is septic arthritis until urgently assessed. Absence of fever does not exclude it. Immunosuppression, prosthetic material, recent joint surgery or injection, skin infection and bacteraemia raise concern. Aspirate and culture when feasible, obtain blood cultures in systemic illness and start emergency treatment according to the receiving pathway. Never inject glucocorticoid into a joint that may be infected.
Eye pain, photophobia, blurred or reduced vision, irregular pupil or intense unilateral redness suggests anterior uveitis rather than uncomplicated conjunctivitis and requires urgent slit-lamp assessment. Severe headache, neurological deficit, meningism or focal weakness is not a standard reactive-arthritis feature. New chest pain, syncope, marked breathlessness or palpitations requires conventional emergency evaluation; rare associations should not distract from common dangerous causes.
Persistent diarrhoea with dehydration, blood, high fever or systemic toxicity needs enteric-infection assessment. Pelvic pain, pregnancy, testicular pain, genital ulceration, severe discharge or suspected sexual assault requires an appropriate urgent and confidential pathway. During NSAID or steroid treatment, gastrointestinal bleeding, acute kidney injury, severe hyperglycaemia, allergy or sepsis requires prompt review. Worsening pain despite treatment, a steadily rising inflammatory response, destructive imaging or failure to regain function should reopen the differential. A label of reactive arthritis must never become a reason to dismiss later evidence of septic, crystal, malignant or chronic inflammatory disease.
Indian Clinical Context
India's 2024 NACO technical guideline is the primary cited national source for STI/RTI diagnosis, syndromic pathways, laboratory-supported care, partner management and stigma-free services. It does not function as a dedicated reactive-arthritis guideline. current guidelines and the public health guidance Scotland sexually acquired reactive-arthritis guidance inform musculoskeletal decisions, but they were developed for UK systems and are not Indian prescribing authority. Their antibiotic, referral and biologic assumptions require checking against Indian labels, NACO guidance, local microbiology and institutional policy.
The Indian differential may include chikungunya and other febrile viral illness, enteric infection, tuberculosis, HIV-associated disease, acute rheumatic fever and common septic arthritis. These should be selected by phenotype and exposure rather than ordered as a ritual panel. A recent positive chikungunya or enteric test does not eliminate a septic joint. Likewise, genital infection may be asymptomatic, particularly in women, so testing must be guided by confidential exposure history rather than stereotypes.
Access differs between private laboratories, primary or district services, medical colleges and NACO-supported Designated STI/RTI Clinics or Suraksha Clinics. Confirm specimen availability, result turnaround, partner services and referral destination. Use non-stigmatising language, consent, chaperones and privacy; do not record unnecessary sexual details in broadly visible documents. Explain the difference between infection treatment and arthritis treatment in the patient's preferred language to reduce antibiotic shopping. The safest India-adapted plan prioritises joint sepsis exclusion, evidence-based STI care, antimicrobial stewardship, affordable monitoring and a defined route for eye or rheumatology review.
NMC Competency Mapping
The 2024 NMC CBME curriculum places this syndrome within General Medicine Topic 7, Rheumatologic problems. GM7.2-GM7.5 address classification and systematic assessment of joint pain, distinction between acute and chronic causes, and separation of arthralgia, arthritis, articular, periarticular, mechanical and inflammatory presentations. Reactive arthritis tests these distinctions through synovitis, enthesitis, dactylitis and inflammatory back pain after infection.
GM7.6-GM7.10 cover common articular and periarticular signs, systemic manifestations, a discriminating history, examination of joints, muscle and skin, and prioritised differential diagnosis. GM7.11-GM7.13 require appropriate work-up, indications for arthrocentesis and interpretation of radiographs. Learners should therefore justify synovial-fluid analysis before calling a hot joint reactive, take a confidential infection history, identify uveitis, and explain why HLA-B27 is neither confirmatory nor exclusionary. Orthopaedics OR3.1 covers bone and joint infection including septic arthritis, and OR3.2 includes participation in supervised joint aspiration.
GM7.14-GM7.22 map to communicating diagnosis, treatment and follow-up; selecting pain relief and systemic treatment; explaining DMARD or biologic principles; incorporating preference and quality-of-life impact; and deciding on specialist consultation. PH2.7 supports NSAID pharmacology and PH2.8 covers drug planning for arthritis. A supervised assessment can require a differential, aspiration plan, STI testing rationale, safe NSAID prescription and eye/sepsis safety-net. This educational mapping does not certify independent arthrocentesis, genital examination, immunosuppression or antimicrobial prescribing.
Key Exam Pearls for NEET PG
Reactive arthritis is a seronegative spondyloarthritis that usually begins one to four weeks after a gastrointestinal or genitourinary infection. Typical triggers are Chlamydia trachomatis, Salmonella, Shigella, Campylobacter and Yersinia. The pattern is asymmetric lower-limb oligoarthritis with enthesitis, especially Achilles or plantar involvement, and possible dactylitis or inflammatory back pain. The complete arthritis-urethritis-conjunctivitis triad is uncommon and not required. Urethritis may be silent, and the trigger may have resolved.
Extra-articular findings include conjunctivitis, anterior uveitis, oral ulcers, keratoderma blennorrhagicum and circinate balanitis. Eye pain, photophobia or reduced vision means urgent uveitis assessment. HLA-B27 supports a spondyloarthritis context and may be associated with persistence but does not diagnose the condition. Inflammatory markers are nonspecific. Stool or genital testing can support a trigger, but a negative test after the infection has cleared does not exclude the syndrome.
The first exam-safe action in a hot monoarthritis is aspiration to exclude sepsis and crystals. Synovial fluid in reactive arthritis is inflammatory but sterile on routine culture; crystals and infection can coexist. Treat an ongoing infection and address partners when sexually transmitted, but do not prescribe long-course antibiotics solely for established post-infectious arthritis after the trigger has been treated. NSAIDs are typical first-line symptomatic therapy; local steroid may follow infection exclusion, and persistent disease may need a DMARD. Distinguish reactive arthritis from disseminated gonococcal infection, psoriatic arthritis, enteropathic arthritis, viral or chikungunya arthritis, rheumatic fever and septic arthritis.
Frequently Asked Questions
Does reactive arthritis mean that bacteria are growing inside the painful joint?
Usually no. Reactive arthritis is an inflammatory response after infection elsewhere, and routine synovial-fluid culture is expected to be sterile. However, that expectation cannot safely distinguish it from septic arthritis at presentation. A hot swollen joint often needs urgent aspiration, Gram stain, culture and crystal analysis before clinicians can rely on the reactive label.
Should everyone with reactive arthritis receive a prolonged course of antibiotics?
No. A current triggering infection should be treated according to the organism, syndrome, pregnancy status and applicable Indian guidance. Current guidelines advises against antibiotic treatment lasting four weeks or longer solely to manage reactive arthritis after the initial gastrointestinal or genitourinary infection has been treated. Ongoing symptoms should prompt reassessment for active infection, reinfection or another diagnosis.
Can a negative HLA-B27 result rule out reactive arthritis?
No. HLA-B27 is neither necessary nor sufficient for diagnosis. It may support a broader spondyloarthritis assessment or help frame prognosis in selected persistent cases, but many affected people are negative and most carriers never develop reactive arthritis. The clinical pattern, timing after infection, exclusion of sepsis and follow-up are more important.
Which eye symptoms with reactive arthritis require urgent specialist assessment?
Eye pain, photophobia, blurred or reduced vision, an irregular pupil or intense unilateral redness may indicate anterior uveitis and require urgent ophthalmic examination. Mild sticky or watery conjunctivitis can occur, but symptoms overlap and visual complaints should not be reassured remotely. Early slit-lamp assessment protects vision and establishes the correct treatment.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic